NCT01596257View on ClinicalTrials.gov

Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation

PHASE2CompletedINTERVENTIONAL

Enrollment

116

Participants

Timeline

Start Date

May 5, 2012

Primary Completion Date

August 30, 2021

Study Completion Date

August 30, 2021

Conditions

Leukemia

Interventions

PROCEDURE

allogeneic hematopoietic stem cell transplantation

Undergo allogeneic hematopoietic stem cell transplant

DEVICE

CliniMACS

Trial Locations (1)

10065

Memorial Sloan Kettering Cancer Center, New York

All Listed Sponsors

lead

Memorial Sloan Kettering Cancer Center

OTHER

NCT01596257 - Bulk Versus Fractionated Stem Cell Infusions in Patients With Hematologic Malignancies Undergoing Stem Cell Transplantation | Biotech Hunter | Biotech Hunter